AcuFocus a maker of corneal inlay, has closed a $65 million financing round led by Cowen Healthcare Royalty Partners. Existing investors SV Life Sciences, Versant Ventures, Carlyle Group, Accuitive Medical Ventures and Bausch & Lomb participated, with Medtronic also joining in the round. Cowen Royalty’s $30 million investment included a $25 million Synthetic Royalty(SM) investment [...]

Intuity Medical Inc., a developer of glucose monitoring technologies for managing diabetes, has closed a second tranche of its Series D financing, bringing the round’s total to $76 million. Accuitive Medical Ventures joined as a new investor. The firm is also backed by Investor Growth Capital, Thomas McNerney and Partners, Venrock, Versant Ventures and U.S. Venture Partners. Intuity Medical is based in Sunnyvale, Calif.

Menlo Park, Calif.-based Nevro Corp., a neuromodulation company focused on relief of chronic pain, has sealed a whopping $58 million round led by new investor Johnson & Johnson Development Corporation. Existing shareholders Aberdare Ventures, Accuitive Medical Ventures, Bay City Capital, Mayo Clinic, MPM Capital and Three Arch Partners also participated. The money will go toward a clinical study in the US and to support the company’s commercialization strategy.

Venture capital-backed biotech company CardioFocus has secured $5 million in debt financing from Silicon Valley Bank. The company has raised venture funding from investors including Accuitive Medical Ventures, Aurora Funds, Kestrel Venture Management, Oxford Biosciences Partners, SV Life Sciences Advisors, HIG Ventures and KBL Healthcare Ventures. The debt financing will help it initiate its pivotal trial in the U.S. and to expand the commercialization of its products in Europe, the company said in a statement. CardioFocus is based in Massachusetts.

We’ll keep bringing you potential (and, some completed) funding opportunities from S.E.C. filings, and, please, if you’re an executive/banker/entrepreneur who knows of a potential deal for a VC, kick it our way. Today, we’ve got companies that just completed some fundraisings, as well as others that are just a hair shy, still. IN THE MARKET [...]

Boston Scientific, based in Natick, Mass., has announced plans to acquire Los Gatos, Calif.-based Sadra Medical, developer of an aortic valve replacement system, to gain entry into the emerging market of structural heart disease. Boston Scientific is paying $193 million in cash, plus additional potential milestone payments of up to $193 million. Sadra Medical is a seven-year-old [...]